These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 373460)

  • 21. Conversion of normal host splenocytes to suppressor cells by tumor-induced suppressor T-cell-derived factor(s): cyclophosphamide treatment reverses inhibitory activity.
    Elgert KD; Foo AS; Burger CJ; Farrar WL
    J Biol Response Mod; 1983; 2(3):238-50. PubMed ID: 6227709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of the joint use of BCG and antithymocyte serum on the growth of a syngeneic tumor in mice].
    Babadzhanov AS; Slavina EG
    Biull Eksp Biol Med; 1983 Feb; 95(2):68-70. PubMed ID: 6600630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumor-specific immunotherapy: active immunotherapy by augmenting the induction of tumor-specific effector T cells through a T-T cell interaction mechanism].
    Kosugi A; Fujiwara H; Hamaoka T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1527-35. PubMed ID: 6236750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell subset interactions in the regulation of syngeneic tumor immunity.
    Perry LL; Greene MI
    Fed Proc; 1981 Jan; 40(1):39-44. PubMed ID: 6450065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune suppression in vivo with antigen-modified syngeneic cells. V. Interacting T cell subpopulations in the suppressor pathway.
    Sherr DH; Benacerraf B; Dorf ME
    J Immunol; 1980 Oct; 125(4):1862-8. PubMed ID: 6997388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of two distinct subpopulations of suppressor cells in rats bearing chemically induced tumors.
    Iguchi S; Ishii Y; Yamaoka H; Sato N; Kikuchi K
    Neoplasma; 1981; 28(1):51-8. PubMed ID: 6456424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors.
    Kudo-Saito C; Schlom J; Camphausen K; Coleman CN; Hodge JW
    Clin Cancer Res; 2005 Jun; 11(12):4533-44. PubMed ID: 15958639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effector mechanisms operative in adoptive therapy of tumor-bearing animals: implications for the use of interleukin-2.
    Greenberg PD; Cheever MA
    J Biol Response Mod; 1984 Oct; 3(5):455-61. PubMed ID: 6239012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cells.
    Tilkin AF; Gomard E; Begue B; Levy JP
    J Immunol; 1984 Jan; 132(1):520-6. PubMed ID: 6228582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of in vivo cytotoxic T lymphocyte activity and reduction of tumor growth by large multivalent immunogen.
    Rogers J; Mescher MF
    J Immunol; 1992 Jul; 149(1):269-76. PubMed ID: 1607658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
    Ishizaka K; Adachi T
    J Immunol; 1976 Jul; 117(1):40-7. PubMed ID: 1084370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunosuppressive phenomena in experimental tumor systems (author's transl)].
    Reme TX
    Pathol Biol (Paris); 1977 Dec; 25(10):735-40. PubMed ID: 349487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model.
    De Boer RJ; Hogeweg P; Dullens HF; De Weger RA; Den Otter W
    J Immunol; 1985 Apr; 134(4):2748-58. PubMed ID: 3156189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.
    Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T
    J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
    Fung PY; Longenecker BM
    Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody.
    HayGlass KT; Naides SJ; Benacerraf B; Sy MS
    J Mol Cell Immunol; 1985; 2(2):107-17. PubMed ID: 2978459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.